Evidence map›Paper›PMID 25880685›Full record

Trial reportBMC ophthalmology2015

Efficacy of 1% carboxymethylcellulose sodium for treating dry eye after phacoemulsification: results from a multicenter, open-label, randomized, controlled study.

Ke Yao, Yongzhen Bao, Jian Ye, Yi Lu, Hongsheng Bi, Xin Tang, Yune Zhao, Jinsong Zhang, Jinling Yang

2 registry-linked trialsOpen access · goldAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in BMC ophthalmology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 25 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 2 pooled it
6.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02028754 phase4completednot on this map

A Study of Sodium Carboxymethylcellulose for Post Cataract Surgery Dry Eye Symptoms

TypeinterventionalSponsorAllerganRan2011 to 2013Enrolled180ConditionsDry Eye Syndromes, CataractArmsSodium Carboxymethylcellulose, Levofloxacin, Prednisolone
NCT02644720 naunknown statusnot on this map

Neural Compensation, Visual Function and Visual Quality in Senile Cataract Patients After Monofocal or Multifocal Intraocular Lens Implantation

TypeinterventionalSponsorSun Yat-sen UniversityRan2014 to 2019Enrolled50ConditionsCataractArmsmultifocal intraocular lens implantation, monofocal intraocular lens implantation, Dexamethasone, multifocal intraocular lens (IOL) (Tecnis ZMB00), monofocal intraocular lens (IOL) (Tecnis ZCB)
3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 2 syntheses or guidelines pooled it, 65 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Review
  7. Review
  8. Article
  9. Article
  10. Observational
  11. Cataract surgery in ocular surface disease.Indian journal of ophthalmology · 2023
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Observational
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 8 institutions in 1 country.

Ke YaoEye Center, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China. xlren@zju.edu.cn.
Yongzhen BaoPeking University People's Hospital, Beijing, China. drbaoyz@sina.com.
Jian YeDaping Hospital, Third Military Medical University, Chongqing, China. yejian1979@163.com.
Yi LuEye, Ear, Nose and Throat Hospital of Fudan University, Shanghai, China. luyiox@163.com.
Hongsheng BiShandong Shierming Eye Hospital, Jinan, China. bihongsheng@126.com.
Xin TangTianjin Eye Hospital, Tianjin, China. tangprofessor@yahoo.com.cn.
Yune ZhaoThe Affiliated Eye Hospital of Wenzhou Medical College, Wenzhou, China. 13819707056@qq.com.
Jinsong ZhangThe Fourth Affiliated Hospital of China Medical University, Shenyang, China. cmu4h-zjs@126.com.
Jinling YangAllergan Information Consulting (Shanghai) Co, Ltd, Shanghai, China. yang_jinlin@allergan.com.
Affiliated Eye Hospital of Wenzhou Medical College · CNArmy Medical University · CNChina Medical University · CNFudan University · CNPeking University · CNSecond Affiliated Hospital of Zhejiang University · CNShandong Shierming Eye Hospital · CNTianjin Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundFor patients who experience dry eye after phacoemulsification, vision and quality of life can significantly deteriorate. In this study, the efficacy and safety of carboxymethylcellulose sodium (CMC) 1% ophthalmic solution combined with conventional therapy in treating dry eye signs and symptoms after phacoemulsification were evaluated.

methodsIn this prospective, multicenter, open-label, controlled study, 180 patients with age-related cataract were randomized to treatment with conventional therapy plus CMC 1% (n = 90) or to conventional therapy only (control group, n = 90) after phacoemulsification and intraocular lens implantation. Tear breakup time (TBUT), the Schirmer test with anesthesia, and fluorescein and lissamine green staining were performed. The Ocular Surface Disease Index (OSDI) questionnaire and a patient subjective symptom evaluation were administered preoperatively (baseline) and postoperatively at 7 and 30 days.

resultsTBUT was significantly longer in the treatment group compared with the control group at day 7 (8.5 ± 5.5 versus 6.6 ± 3.8 s; P = 0.0475) and day 30 (9.0 ± 5.9 versus 6.7 ± 4.8 s; P = 0.0258) after surgery. Compared with baseline, TBUT significantly increased in patients in the treatment group (P < 0.001 at both day 7 and day 30) with a presurgical diagnosis of dry eye, but significantly decreased in patients in the control group (P < 0.02 at both day 7 and day 30) with no prior diagnosis of dry eye. Fluorescein and lissamine staining, OSDI questionnaire and subjective symptom scores all improved from baseline, with no significant differences between the two groups. No significant differences in tolerability and safety were observed between the group receiving CMC and conventional therapy, and those receiving conventional therapy only.

conclusionTreatment with CMC 1% can provide significant improvement in tear film stability after phacoemulsification for age-related cataract.

trial registrationClinicalTrials.gov identifier NCT02028754 (Date of registration: Jan. 6, 2014).

Indexed as

AgedAged, 80 and overCarboxymethylcellulose SodiumDry Eye SyndromesFemaleFollow-Up StudiesHumansMaleMiddle AgedOphthalmic SolutionsPhacoemulsificationProspective StudiesQuality of LifeSurveys and QuestionnairesCarboxymethylcellulose SodiumOphthalmic Solutions

Identifiers

PMID25880685
PMCPMC4407782
OpenAlexW2079689334

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.